In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Two columns page  

Atrial Fibrillation (Management of) 2010 and Focused Update (2012)

ESC Clinical Practice Guidelines

Professor Bax talks about the ESC Guidelines

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, occurring in 1–2% of the general population.

Cardiovascular Pharmacology and Pharmacotherapy
Invasive Electrophysiology and Ablation
Atrial Fibrillation
Guidelines version available to download
Published in 2012
Reference European Heart Journal (2012) 33, 2719–2747
Published in 2010
Reference European Heart Journal (2010) 31, 2369–2429
Published in 2012
Reference Corrigendum-AFib-Focused-Update-2012-EHJ-doi:10.1093/eurheartj/eht027
Published in 2011
Reference doi:10.1093/eurheartj/ehq512
Published in 2012
Reference Table of Contents
  • PDA
  • Published in 2012
    Reference Download the PDA version
    Published in 2012
    Reference Slides AFIB focused update 2012
    Published in 2011
    Reference 2010 Guidelines slides on AFIB
    Published in 2012
    Reference CME Questions AFIB
    Published in 2010
    Reference AFIB - Additional References
    Published in 2011
    Reference ESC Statement on Dronedarore
    Authors

    Focused update 2012
    A. John Camm (Chairperson),Gregory Y.H. Lip, Dan Atar, Raffaele de Caterina, Gerhard Hindricks, Stefan Hohnloser, Paulus Kirchhof, Irina Savelieva

    Version 2010
    A. John Camm FESC (Chairperson), Paulus Kirchhof FESC, Gregory Y. H. Lip FESC, Ulrich Schotten, Irene Savelieva, Sabine Ernst FESC, Isabelle C. Van Gelder FESC, Nawwar Al-Attar, Gerhard Hindricks FESC, Bernard Prendergast FESC, Hein Heidbuchel FESC, Ottavio Alfieri FESC, Annalisa Angelini FESC, Dan Atar FESC, Paolo Colonna FESC, Raffaele De Caterina FESC, Johan De Sutter FESC, Andreas Goette, Bulent Gorenek FESC, Magnus Heldal FESC, Stefan Hohnloser FESC, Philippe Kolh FESC, Jean-Yves Le Heuzey FESC, Piotr Ponikowski FESC, Frans H. Rutten

    Table of contents: Full Text (ESC Clinical Practice Guidelines)

    Abbreviations and acronyms

    Preamble

    Introduction

    • Epidemiology
    • Mechanisms of atrial fibrillation

    Detection, 'natural' history and acute management

    • Definition
    • Detection
    • "Natural" time course
    • Electrocardiogram techniques to diagnose and monitor atrial fibrillation
    • Types of atrial fibrillation
    • Initial management
    • Clinical follow-up

    Management

    Antithrombotic management

    • Risk stratification for stroke and thrombo-embolism
    • Antithrombotic therapy
    • Anticoagulation therapy with vitamin K antagonist vs control
    • Antiplatelet therapy vs control
    • Anticoagulation therapy with vitamin k antagonist vs antiplatelet therapy
    • Other antithrombotic drug regimens
    • Investigational agents
    • Current recommendations for antithrombotic therapy
    • Risk of bleeding
    • Optimal international normalized ratio
    • Special situations
    • paroxymal atrial fibrilllation
    • Perioperative anticoagulation
    • Stable vascular disease
    • ACS and/ or PCI
    • Elective PCI
    • Non-St elevation myocardial infraction
    • Acute ST segment elevation myocardial infarction with primary percutaneous intervention
    • Acute stroke
    • Atrial flutter
    • Cardioversion
    • Tansoesophageal echocardiogram-guided cardioversion
    • Non-pharmacological methods to prevent stroke

    Rate and rhythm management

    • Acute rate and rhythm management
    • Acute rate control
    • Pharmacological conversion
    • "Pill-in-the-pocket" approach
    • Direct current cardioversion

    Long term management

    • Rate and rhythm control
    • long term rate control
    • Parmacological rate control
    • Atrioventricular node abaltation and modification
    • Long term rhythm control
    • Antiarrhythmic drugs to maintain sinus rhythm
    • Left atrial catheter ablation
    • Surgical ablation

    Upstream therapy

    • Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers
    • Aldosterone antagosnists
    • Statins
    • Polyunsaturated fatty acids

    Specific population

    • Heart failure
    • Athletes
    • Valvular heart disease
    • Acute coronoray syndromes
    • Diabetes mellitus
    • The elderly
    • Pregnancy
    • Post-operative atrial fibrillation
    • Hyperthyroidism
    • Wolf-Parkinson-White syndrome
    • Hypertrophic cardiomyopathy
    • Pulmonary disease

     

     

     

    Back to top

    Who we are

    What we do

    How we work

    More ESC